Table 1. Comparison of basic demographic and clinical characteristics between pulmonary and extra-pulmonary tuberculosis patients.
Variables | Total (N = 2771) | PTB (N = 1121) | EPTB (N = 1650) | p-value |
---|---|---|---|---|
Gender (N, %) | ||||
Males | 1508 (54.4) | 759 (67.7) | 749 (45.4) | <0.001μ* |
Females | 1263 (45.6) | 362 (32.3) | 901 (54.6) | |
Age categories (years) (N, %) | ||||
0–14 | 167 (6) | 30 (2.7) | 137 (8.3) | <0.001 μ* |
15–59 | 2068 (74.6) | 861 (76.8) | 1207 (73.2) | 0.035μ* |
≥60 years | 536 (19.4) | 230 (20.5) | 306 (18.5) | 0.190 μ* |
Residence (N, %) | ||||
Rural | 1144 (41.3) | 496 (44.2) | 648 (39.3) | 0.009 μ* |
Urban | 1627 (58.7) | 625 (55.8) | 1002 (60.7) | |
Treatment regimen | ||||
Fixed dose combination (N, %) | 732 (26.4) | 317 (28.3) | 415 (25.2) | 0.067 μ* |
Separate tablets | 2039 (73.6) | 804 (71.7) | 1235 (74.8) | |
Therapy duration (months) (Mean ± SD) | 7.46 ± 4.3 | 6.6 ± 3.5 | 8 ± 4.6 | <0.001 μ** |
Disease outcomes (N, %) | ||||
Relapse | 10 (0.4) | 3 (0.3) | 7 (0.4) | 0.700 μ* |
Death | 79 (2.9) | 41 (3.7) | 38 (2.3) | 0.035 μ* |
Treatment failure | 5 (0.2) | 4 (0.4) | 1 (0.1) | 0.100 μ* |
N: Number; PTB: Pulmonary tuberculosis; EPTB: Extra-pulmonary tuberculosis; SD: Standard deviation
*: Chi-square test
**: t-test.
μ: p-value between PTB and EPTB.